Finzati - Logo
RMD logo

ResMed Inc.

RMDMedical - Devices
$228.35
-0.84 (-0.37%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$32.89B
Growth
-100.0%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 26.9%Positive revenue growth · 12.7%Consistent free cash flow · 4/5Manageable debt level · 0.13Healthy liquidity · 3.1
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$228.35
Change-0.37%
Market Cap$32.89B
52W Range180.27 - 293.81
Beta0.75
Gross Margin61.06%
Oper. Margin33.37%
Profit Margin26.94%
Debt/Eq0.13
Current Ratio3.10
Quick Ratio2.42
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

77
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score
Stable or improving margins · 26.9%Positive revenue growth · 12.7%Consistent free cash flow · 4/5Manageable debt level · 0.13Healthy liquidity · 3.1

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$213.00
Mean
$239.67
Median
$230.00
High
$300.00

Company Overview

IPO: 6/2/1995
Industry: Medical - Devices
P/B i: 0.00
Debt / Equity i: 0.13
Operating Margin: 33.37%
Net Margin: 26.94%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.13
Current Ratio: 3.10
Quick Ratio: 2.42
Status: Strong

Insider Transactions

Recent executive and insider activity

Farrell Michael J.
Transaction: 08/07/2026
SELL
Change
-4,991
Price
$146.34
Filing
08/11/2026
Type
SELL
Farrell Michael J.
Transaction: 08/07/2026
SELL
Change
-4,991
Price
$205.69
Filing
08/11/2026
Type
SELL
FARRELL PETER C
Transaction: 08/05/2026
SELL
Change
-8,000
Price
$225.00
Filing
08/06/2026
Type
SELL